Bicyclo[2.2.2]octyltriazole inhibitors of 11β-HSD1

被引：0
|
作者：
Waddell, Sherman T. [1 ]
Gu, Xin [1 ]
Santorelli, Gina [1 ]
Graham, Donald [1 ]
Balkovec, James [1 ]
机构：
[1] Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 231卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
5-MEDI
引用
收藏
页数：2
相关论文
共 50 条
  • [31] 11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease
    Anderson, Anna
    Walker, Brian R.
    DRUGS, 2013, 73 (13) : 1385 - 1393
  • [32] Discovery of potent and selective inhibitors of 11β-HSD1 for the treatment of metabolic syndrome
    Richards, Steven
    Sorensen, Bryan
    Jae, Hwan-Soo
    Winn, Marty
    Chen, Yixian
    Wang, Jiahong
    Fung, Steven
    Monzon, Katina
    Frevert, Ernst U.
    Jacobson, Peer
    Sham, Hing
    Link, J. T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (24) : 6241 - 6245
  • [33] Identification of adamantyl urea derivatives as novel and selective 11β-HSD1 inhibitors
    Fujiwara, Hiroaki
    Suda, Hitoshi
    Nishimura, Tamiki
    Nunami, Noriko
    Sato, Yasuhiro
    Negishi, Toru
    Hiramine, Yasushi
    Kohayakawa, Chie
    Horiuchi, Yoshihiro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [34] Discovery and optimization of benzenesulfonanilide derivatives as a novel class of 11β-HSD1 inhibitors
    Rew, Yosup
    DeGraffenreid, Michael
    He, Xiao
    Jaen, Juan C.
    McMinn, Dustin L.
    Sun, Daqing
    Tu, Hua
    Ursu, Stefania
    Powers, Jay P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (11) : 3786 - 3790
  • [35] Synthesis and biological evaluation of heterocycle containing adamantane 11β-HSD1 inhibitors
    Yeh, Vince S. C.
    Patel, Jyoti R.
    Yong, Hong
    Kurukulasuriya, Ravi
    Fung, Steven
    Monzon, Katina
    Chiou, William
    Wang, Jiahong
    Stolarik, Deanne
    Imade, Hovis
    Beno, David
    Brune, Michael
    Jacobson, Peer
    Sham, Hing
    Link, J. T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (20) : 5414 - 5419
  • [36] Predicting Putative Inhibitors of 17β-HSD1
    Heinzerling, Lennart
    Hartmann, Rolf W.
    Frotscher, Martin
    Neumann, Dirk
    MOLECULAR INFORMATICS, 2010, 29 (10) : 695 - 705
  • [37] A highly efficient synthesis of potent and selective butyrolactam inhibitors of 11β-Hsd1
    Yeh, Vince S. C.
    Kurukulasuriya, Ravi
    Kerdesky, Francis A.
    ORGANIC LETTERS, 2006, 8 (18) : 3963 - 3966
  • [38] A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD):: flavanone selectively inhibits 11β-HSD1 reductase activity
    Schweizer, RAS
    Atanasov, AG
    Frey, BM
    Odermatt, A
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 212 (1-2) : 41 - 49
  • [39] Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)
    Sun, Daqing
    Wang, Zhulun
    Di, Yongmei
    Jaen, Juan C.
    Labelle, Marc
    Ma, Ji
    Miao, Shichang
    Sudom, Athena
    Tang, Liang
    Tomooka, Craig S.
    Tu, Hua
    Ursu, Stefania
    Walker, Nigel
    Yan, Xuelei
    Ye, Qiuping
    Powers, Jay P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) : 3513 - 3516
  • [40] 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors Still Improve Metabolic Phenotype in Male 11β-HSD1 Knockout Mice Suggesting Off-Target Mechanisms
    Harno, Erika
    Cottrell, Elizabeth C.
    Yu, Alice
    DeSchoolmeester, Joanne
    Gutierrez, Pablo Morentin
    Denn, Mark
    Swales, John G.
    Goldberg, Fred W.
    Bohlooly-Y, Mohammad
    Andersen, Harriet
    Wild, Martin J.
    Turnbull, Andrew V.
    Leighton, Brendan
    White, Anne
    ENDOCRINOLOGY, 2013, 154 (12) : 4580 - 4593
12345